Full Text View
Tabular View
No Study Results Posted
Related Studies
An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes
This study has been completed.
Study NCT00065312   Information provided by Eli Lilly and Company
First Received: July 21, 2003   Last Updated: July 18, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
naveglitazar
Additional drug interventions recognized in this trial
Hypoglycemic Agents
More general drug interventions related to this trial
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services